Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Shares Issued (2016 - 2025)

Historic Shares Issued for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $40.2 million.

  • United Therapeutics' Shares Issued rose 2369.23% to $40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.6 million, marking a year-over-year decrease of 2498.14%. This contributed to the annual value of $152.5 million for FY2024, which is 5561.22% up from last year.
  • Latest data reveals that United Therapeutics reported Shares Issued of $40.2 million as of Q3 2025, which was up 2369.23% from $18.1 million recorded in Q2 2025.
  • In the past 5 years, United Therapeutics' Shares Issued ranged from a high of $61.4 million in Q1 2023 and a low of $4.3 million during Q1 2022
  • In the last 5 years, United Therapeutics' Shares Issued had a median value of $18.1 million in 2025 and averaged $24.4 million.
  • Over the last 5 years, United Therapeutics' Shares Issued had its largest YoY gain of 132790.7% in 2023, and its largest YoY loss of 8684.68% in 2023.
  • Quarter analysis of 5 years shows United Therapeutics' Shares Issued stood at $7.7 million in 2021, then soared by 620.78% to $55.5 million in 2022, then crashed by 86.85% to $7.3 million in 2023, then surged by 252.05% to $25.7 million in 2024, then soared by 56.42% to $40.2 million in 2025.
  • Its last three reported values are $40.2 million in Q3 2025, $18.1 million for Q2 2025, and $16.6 million during Q1 2025.